Medical Journals

Angiotensin Ii Controls Occludin Function and is Required for Blood Brain Barrier Maintenance: Relevance to Multiple Sclerosis.

Authors:
  • Wosik Karolina
  • Cayrol Romain
  • Dodelet-Devillers Aurore
  • Berthelet France
  • Bernard Monique
  • Moumdjian Robert
  • Bouthillier Alain
  • Reudelhuber Timothy L
  • Prat Alexandre

From: Neuroimmunology Research Laboratory, Center for Study of Brain Diseases, Clinical Research Institute of Montreal, MontrĂ©al, Quebec, Canada H2L 4M1.

The Journal of neuroscience : the official journal of the Society for Neuroscience

  • Publish Date: Aug 2007
  • ISSN: 1529-2401
  • Volume: 27
  • Issue: 34
  • Pages: 9032-42
  • Medium: Internet
  • Language: English
  • Citation (JAMA): Wosik Karolina, Cayrol Romain, Dodelet-Devillers Aurore, et al. Angiotensin Ii Controls Occludin Function and is Required for Blood Brain Barrier Maintenance: Relevance to Multiple Sclerosis.. J. Neurosci. Aug 2007;27:9032-42

Abstract

The blood-brain barrier (BBB) restricts molecular and cellular trafficking between the blood and the CNS. Although astrocytes are known to control BBB permeability, the molecular determinants of this effect remain unknown. We show that angiotensinogen (AGT) produced and secreted by astrocytes is cleaved into angiotensin II (AngII) and acts on type 1 angiotensin receptors (AT1) expressed by BBB endothelial cells (ECs). Activation of AT1 restricts the passage of molecular tracers across human BBB-derived ECs through threonine-phosphorylation of the tight junction protein occludin and its mobilization to lipid raft membrane microdomains. We also show that AGT knock-out animals have disorganized occludin strands at the level of the BBB and a diffuse accumulation of the endogenous serum protein plasminogen in the CNS, compared with wild-type animals. Finally, we demonstrate a reduction in the number of AGT-immunopositive perivascular astrocytes in multiple sclerosis (MS) lesions, which correlates with a reduced expression of occludin similarly seen in the CNS of AGT knock-out animals. Such a reduction in astrocyte-expressed AGT and AngII is dependent, in vitro, on the proinflammatory cytokines tumor necrosis factor-alpha and interferon-gamma. Our study defines a novel physiological role for AngII in the CNS and suggests that inflammation-induced downregulation of AngII production by astrocytes is involved in BBB dysfunction in MS lesions.

Mesh Headings (Keywords): Adult, Angiotensin II, Angiotensinogen, Animals, Astrocytes, Blood-Brain Barrier, Capillary Permeability, Cells, Cultured, Cerebral Cortex, Culture Media, Conditioned, Cytokines, Endothelial Cells, Fetus, Gene Expression Regulation, Humans, Male, Membrane Microdomains, Membrane Proteins, Mice, Mice, Knockout, Middle Aged, Multiple Sclerosis, Receptors, Angiotensin, S100 Proteins


Check for Full Text / PubMed Unique Identifier (PMID): 17715340


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.